slide1
Download
Skip this Video
Download Presentation
Components of Severity

Loading in 2 Seconds...

play fullscreen
1 / 1

Components of Severity - PowerPoint PPT Presentation


  • 190 Views
  • Uploaded on

Classification of Severity (5-11 years of age). Components of Severity. Persistent. Intermittent. Mild Moderate Severe. Daily. Symptoms. ≤ 2 days/wk. >2 days/wk. Throughout the day. Nocturnal awakenings. <2 /month. 3-4/month. > Once a wk. Often 7 days/wk. Short acting

loader
I am the owner, or an agent authorized to act on behalf of the owner, of the copyrighted work described.
capcha
Download Presentation

PowerPoint Slideshow about ' Components of Severity' - dysis


An Image/Link below is provided (as is) to download presentation

Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.


- - - - - - - - - - - - - - - - - - - - - - - - - - E N D - - - - - - - - - - - - - - - - - - - - - - - - - -
Presentation Transcript
slide1

Classification of Severity (5-11 years of age)

Components of Severity

Persistent

Intermittent

Mild Moderate Severe

Daily

Symptoms

≤ 2 days/wk

>2 days/wk

Throughout the day

Nocturnal

awakenings

<2 /month

3-4/month

> Once a wk

Often 7 days/wk

Short acting

Β2-agonist for

Symptoms control

Impairment

≤2 days/wk

>2 days/wk

Not daily

daily

Several times a day

Limitation of

Normal

Activity

None

Minor

Some

Extreme

Normal FEV1 between

Exacerbations

FEV1 >80% predicted

FEV1/FVC >85%

FEV1 >80%

Predicted,

FEV1/FVC >80%

FEV1:60-80%

Predicted

FEVV!/FVC

75-80%

FEV1 <60% predicted

FEV?FVC <75%

Lung Function

Exacerbations

Requiring oral

corticosteroids

0-1 per year

≥ 2 per year

RISK

Consider severity and interval since last exacerbation. Frequency and severity may

Fluctuate over time for patients in any severity category

Relative annual risk of exacerbation may be related to FEV1

Recommended

Step for initiating therapy

Step 3 medium

Dose ICS

Step 3 medium ose ICS

Consider short course of oral corticosteroids

In 2-6 wks, evaluate level of asthma control and adjust therapy accordingly

ad